Evidence map›Paper›PMID 20200092›Full record

ArticleAmerican journal of physiology. Renal physiology2010

Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.

Zhengrong Guan, Barry S Fuller, Tatsuo Yamamoto, Anthony K Cook, Jennifer S Pollock, Edward W Inscho

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  10. Article
  11. Article
  12. Review
  13. P2 receptors in renal autoregulation.Current vascular pharmacology · 2014
    Review
  14. Article
  15. Article
  16. Renal microvascular dysfunction, hypertension and CKD progression.Current opinion in nephrology and hypertension · 2013
    Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Zhengrong GuanDept. of Physiology, Medical College of Georgia, 1120 15th St., Augusta, GA 30912, USA.
Barry S Fuller
Tatsuo Yamamoto
Anthony K Cook
Jennifer S Pollock
Edward W Inscho
Augusta University · USHamamatsu University · JP

Funding

Vascular Rho-kinase Signaling in Angiotensin II hypertenP01HL074167 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BRANDS, MICHAEL W. · 2004 to 2008
$10.5M
TLR4 in the Regulation of Renal Microvascular FunctionR01DK044628 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI INSCHO, EDWARD W · 2000 to 2021
$6.2M
Nitric Oxide Synthase Isoforms in the KidneyR01HL060653 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI POLLOCK, JENNIFER S · 1999 to 2010
$2.5M
The Inflammatory Cytokines, MCP-1 and TGF-Beta, Mediate Renal Autoregulatory ImpaR01HL098135 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI INSCHO, EDWARD W · 2010 to 2014
$1.8M
PURINERGIC REGULATION OF THE RENAL MICROVASCULATURER29DK044628 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI INSCHO, EDWARD W. · 1994 to 1998
–
NHLBI NIH HHS HL074167NHLBI NIH HHS HL098135NHLBI NIH HHS HL60653NHLBI NIH HHS P01 HL074167NHLBI NIH HHS R01 HL060653NHLBI NIH HHS R01 HL098135NIDDK NIH HHS DK44628NIDDK NIH HHS R01 DK044628NIDDK NIH HHS R29 DK044628
6 · The paper itself

Abstract

Inflammatory factors are elevated in animal and human subjects with hypertension and renal injury. We hypothesized that inflammation contributes to hypertension-induced renal injury by impairing autoregulation and microvascular reactivity to P2X(1) receptor activation. Studies were conducted in vitro using the blood-perfused juxtamedullary nephron preparation. Rats receiving ANG II (60 ng/min) infusion were treated with the anti-inflammatory agent pentosan polysulfate (PPS) for 14 days. The magnitude and progression of hypertension were similar in ANG II and ANG II+PPS-treated rats (169 ± 5 vs. 172 ± 2 mmHg). Afferent arterioles from control rats exhibited normal autoregulatory behavior with diameter decreasing from 18.4 ± 1.6 to 11.4 ± 1.7 μm when perfusion pressure was increased from 70 to 160 mmHg. In contrast, pressure-mediated vasoconstriction was markedly attenuated in ANG II-treated rats, and diameter remained essentially unchanged over the range of perfusion pressures. However, ANG II-treated rats receiving PPS exhibited normal autoregulatory behavior compared with ANG II alone rats. Arteriolar reactivity to ATP and β,γ-methylene ATP was significantly reduced in ANG II hypertensive rats compared with controls. Interestingly, PPS treatment preserved normal reactivity to P2 and P2X(1) receptor agonists despite the persistent hypertension. The maximal vasoconstriction was 79 ± 3 and 81 ± 2% of the control diameter for ATP and β,γ-methylene ATP, respectively, similar to responses in control rats. PPS treatment significantly reduced α-smooth muscle actin staining in afferent arterioles and plasma transforming growth factor-β1 concentration in ANG II-treated rats. In conclusion, PPS normalizes autoregulation without altering ANG II-induced hypertension, suggesting that inflammatory processes reduce P2X(1) receptor reactivity and thereby impair autoregulatory behavior in ANG II hypertensive rats.

Indexed as

ActinsAdenosine TriphosphateAngiotensin IIAnimalsAnti-Inflammatory AgentsArteriolesBlood PressureDisease Models, AnimalHomeostasisHypertensionKidneyMalePentosan Sulfuric PolyesterRatsRats, Sprague-DawleyReceptors, Purinergic P2X1Acta2 protein, ratActinsAdenosine TriphosphateAngiotensin IIAnti-Inflammatory AgentsPentosan Sulfuric PolyesterReceptors, Purinergic P2X1Transforming Growth Factor beta1

Identifiers

PMID20200092
PMCPMC2867410
OpenAlexW2144297622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.